Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
50 hedge funds and large institutions have $135M invested in Augmedix, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 2 closing their positions.
1,050% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 2
203% more capital invested
Capital invested by funds: $44.4M → $135M (+$90.3M)
72% more funds holding
Funds holding: 29 → 50 (+21)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more call options, than puts
Call options by funds: $134K | Put options by funds: $112K
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.52M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$4.32M |
| 3 |
GIPM
G2 Investment Partners Management
New York
|
+$1.97M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.4M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$4.01M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.42M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$1.22M |
| 4 |
SC
Samjo Capital
New York
|
-$1M |
| 5 |
CPA
Cowen Prime Advisors
New York
|
-$337K |
AUGX Hedge Fund Activity: Q2 2023 in Review
50 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q2 2023, worth a combined $135M — up 203% from $44.4M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AUGX positions and 2 closed out — a net gain of 21 holders — while 10 added to existing stakes and 13 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $6.52M. The largest seller was Russell Investments Group, cutting an estimated $4.01M.
- 50 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q2 2023, up from 29 in Q1 2023.
- Funds reported $135M of Augmedix, Inc. Common Stock stock for Q2 2023, up 203% quarter-over-quarter.
- 23 funds opened new Augmedix, Inc. Common Stock positions in Q2 2023 and 2 closed out, a net change of +21 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q2 2023 was Point72 Asset Management, an estimated $6.52M added.
- The largest Augmedix, Inc. Common Stock seller in Q2 2023 was Russell Investments Group, an estimated $4.01M sold.
Based on aggregated 13F filings for Q2 2023.